China Shineway Pharmaceutical Group Limited
CSWYF
$0.9398
$0.07378.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -55.16% | -54.80% | 23.35% | 21.48% | 20.13% |
| Total Depreciation and Amortization | 53.66% | 53.29% | -9.33% | -10.70% | -127.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -118.16% | -118.30% | 45.97% | 46.79% | 218.41% |
| Change in Net Operating Assets | 858.08% | 865.77% | -- | -- | -92.11% |
| Cash from Operations | -34.48% | -33.96% | 69.85% | 67.28% | -8.95% |
| Capital Expenditure | 30.80% | 30.25% | -46.67% | -44.45% | -43.52% |
| Sale of Property, Plant, and Equipment | -26.61% | -26.04% | -74.89% | -75.28% | 57.34% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -403.98% | -406.40% | 1,143.61% | 1,127.83% | 92.93% |
| Cash from Investing | -9,762.41% | -9,839.97% | 244.78% | 242.60% | 126.44% |
| Total Debt Issued | -- | -- | 10.00% | 10.00% | -- |
| Total Debt Repaid | -14.08% | -14.08% | -9,476.91% | -9,476.91% | -0.16% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.37% | -1.17% | -34.22% | -32.19% | 1.58% |
| Other Financing Activities | -41.05% | -41.05% | -1,567.84% | -1,567.84% | -750.53% |
| Cash from Financing | -2.08% | -2.89% | -567.31% | -560.24% | -0.84% |
| Foreign Exchange rate Adjustments | -3,365.57% | -3,392.51% | -46.42% | -47.23% | -129.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.16% | -118.30% | -0.98% | -2.48% | -8.70% |